about
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of no...
Read More
11.96
-0.22
(-1.81%)
58,878
XNAS Volume
XNAS 03 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for FibroGen Inc is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
FibroGen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..